ALT shares drop over 20% after updated pemvidutide week 48 data; see FDA's stance on non-invasive fibrosis tests. Click here ...
William Blair has hand-picked its top five stock recommendations for 2026, selections that include three clinical-stage ...
A University of Maryland, Baltimore County (UMBC) study, published in Nature Communications, uncovers how ...
At the 13-week primary endpoint, ASC30 once-daily tablets showed dose-dependent placebo-adjusted mean body weight reductions of 5.4%, 7.0% and 7.7% for 20 mg, 40 mg and 60 mg, respectively. No plateau ...
CRB-913 was safe and well-tolerated across all doses studiedDaily neuropsychiatric assessments using CSSRS, PHQ-9, and GAD-7 were negative for all participantsA placebo-adjusted mean weight loss of 2.
Keep reading to learn how biomarker-guided cardioprotection may improve heart outcomes during anthracycline cancer treatment.
Novel PTH analog achieves sustained calcium elevation for >3 days from single oral tablet, supporting development path toward once-daily alternative to daily injectionsJERUSALEM, Dec. 22, 2025 (GLOBE ...
Many are familiar with CPAP machines to treat sleep apnea, but fewer realize an oral appliance is an effective alternative. So how do you know if you’re a good candidate?
Discusses Latest Phase III Updates for Azetukalner in Epilepsy and Commercial Launch Preparation December 10, 2025 ...
Stifel analysts said the label for cardiac myosin inhibitor Myqorzo is in line with their expectations and is differentiated compared with BMS’ Camzyos.
Positive Results in the EMBOLD study of relutrigine showed a 53% placebo-adjusted reduction in seizures (p < 0.0002), 66% increase in motor ...
CPAP therapy can help you decrease snoring and improve your sleep by keeping your airways open. Insurance often covers CPAP machines, which cost between $350 and $3,000. Using a CPAP machine every ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback